Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 10/09/20101 min de leitura
Schmid Laboratories, Inc. et al.; Withdrawal of Approval of Five New Drug Applications
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is withdrawing approval of five new drug applications (NDAs) from multiple holders of these applications. The basis for the withdrawals is that the holders of the applications have repeatedly failed to file required annual reports for the applications.
Idioma original da fonte: Federal Register — Health and Human ServicesAbrir o comunicado original →